Zeocin™

InvivoGen Kontakt z doradcą
Selective antibiotic for the Sh ble gene
Zeocin™

Zeocin™ | Selection antibiotic: endotoxin tested, sterile reagent

InvivoGen is the sole worldwide producer of Zeocin™.

Zeocin™ is a formulation of phleomycin D1, a copper-chelated glycopeptide antibiotic produced by Streptomyces CL990. Zeocin™ causes cell death by intercalating into DNA and cleaving it.

The action of Zeocin™ is effective on most aerobic cells. Therefore, Zeocin™ is a popular and effective antibiotic for the selection of vectors bearing the Sh ble gene in a variety of cells types (bacteria, eukaryotic microorganisms, plant and animal cells).

Resistance to Zeocin™ is conferred by the Sh ble gene product from Streptoalloteichus hindustanus, which inactivates Zeocin™ upon binding to the antibiotic [1-3].

Sh ble is a small 370bp-sized gene and is carried in a number of InvivoGen’s vectors.

Typically, mammalian cells are sensitive to Zeocin™ concentrations of 50-400 µg/ml, and bacteria to 25 µg/ml.

For research use only

References:

  1. Drocourt D. et al., 1990. Cassettes of the Streptoalloteichus hindustanus ble gene for transformation of lower and higher eukaryotes to phleomycin resistance. Nucl. Acids. Res. 18: 4009.
  2. Gatignol A. et al., 1988. FEBS Letters. 230: 171-5.
  3. Dumas P. et al., 1994. Embo J. 242 (5) 595-601.

Podobne produkty

Lucia Luciferase Reporter Gene System

Lucia Luciferase Reporter Gene System

InvivoGen
Więcej
Phleomycin

Phleomycin

InvivoGen
Więcej
G418 (Geneticin)

G418 (Geneticin)

InvivoGen
Więcej